All lobbying filings

AVENUE SOLUTIONS

AVENUE SOLUTIONS filed a Q3 report for MODERNA, INC. on October 20, 2026, reporting $50,000 in lobbying income.

Lobbying for MODERNA, INC. · Biotechnology company

All filings by AVENUE SOLUTIONS · Everything MODERNA, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to vaccine safety and approval; Issues related to FDA's approval of Moderna's flu vaccine; Issues related to Messenger RNA (mRNA) therapies

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.